Beneficial Bancorp Q2 Results Top Estimates

Beneficial Bancorp Q2 Results Top Estimates

Beneficial Bancorp reported Q2 earnings of $0.13 per diluted share compared with an income of $0.04 per share a year ago, beating the $0.11 average estimate from analysts polled by Capital IQ. Total revenue, comprised of net interest income and non-interest income, rose to $49.2 million from $44.8 million a year ago, but coming in above the $45.4-million consensus. “Overall economic activity slowed in our markets during the quarter, which […]

Read More ˃
Horizon Pharma to Present Data

Horizon Pharma to Present Data

Horizon Pharma said Friday it plans to present data from a study of its Procysbi treatment for people with nephropathic cystinosis compared to immediate-release cysteamine, at the Cystinosis Research Network 2017 Family Conference in Snowbird, Utah, on Saturday. In the study, patients receiving Procysbi had a 26% reduction in exhaled dimethyl sulphide–a metabolite of cysteamine bitartrate associated with halitosis (i.e., bad breath)–compared to those receiving immediate-release cysteamine. The study is […]

Read More ˃
IHS Markit to Offer Senior Notes

IHS Markit to Offer Senior Notes

IHS Markit, a provider of critical information, analytics and solutions, said pre-market Monday that it will offer an additional $250 million of its 4.75% senior notes due 2025 in a private placement transaction. IHS Markit has previously issued $500 million of its 4.75% senior notes due 2025 under an indenture, dated Feb. 9, among IHS Markit, the guarantors party thereto and Wells Fargo Bank, National Association, as trustee. IHS Markit […]

Read More ˃
GlaxoSmithKline Partnering with Exscientia

GlaxoSmithKline Partnering with Exscientia

GlaxoSmithKline is partnering with privately-owned Exscientia to use artificial intelligence to help develop new drugs, according to a report from Reuters. The deal with Exscientia will allow GlaxoSmithKline to search drug candidates for up to 10 disease-related targets by using super computers and machine-learning systems to predict how molecules will behave. Exscientia’s artificial intelligence system could deliver drug candidates in “roughly one-quarter of the time and at one-quarter of the […]

Read More ˃
Air Products and Chemicals Wins Contract

Air Products and Chemicals Wins Contract

Air Products and Chemicals said Tuesday that it won a contract to supply industrial gases to support the capacity expansion of the Tianjin facility of Semiconductor Manufacturing International Corporation (SMI). The company will build an on-site nitrogen plant and use existing air separation unit and liquid gases capacity to supply a range of high-purity bulk gases for the facility. Shares were little changed in midday trade.

Read More ˃